Evidence map›Paper›PMID 24126603›Full record

ArticleCurrent microbiology2014

Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Pablo A Nuñez, Rosalia Moretta, Paula Ruybal, Silvina Wilkowsky, Marisa D Farber

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pablo A NuñezInstituto de Biotecnología, Instituto Nacional de Tecnología Agropecuaria (CICVyA-INTA), Los Reseros y Las Cabañas, B1712WAA, Hurlingham, Buenos Aires, Argentina, pb.nunez@gmail.com.
Rosalia Moretta
Paula Ruybal
Silvina Wilkowsky
Marisa D Farber
National Agricultural Technology Institute · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaplasma marginale is a tick-transmitted Gram-negative intraerythrocytic bacterium and the etiological agent of bovine Anaplasmosis. Even though considerable research efforts have been undertaken, Anaplasmosis vaccine development remains a challenging field. Outer-membrane-specific antigens responsible for the ability of more complex immunogens could have a significant role in the protective response. Thus, the identification of outer-membrane antigens represents a major goal in the development of bacterial vaccines. Considering that 40 % of the annotated proteins in A. marginale remain as hypothetical, we selected three candidate antigens, AM1108, AM127, and AM216 based on experimental evidence, in silico structure prediction of β-barrel outer membrane, and orthology clustering. Sequence alignment and analysis demonstrated a high degree of conservation for the three proteins between the isolates from Argentina compared to the American strains. We confirmed the transcription of the three genes in the intraerythrocytic stage. AM1108 and AM216 recombinant proteins elicited specific T-cell response proliferation and a significant rise in TNF-α and IFN-γ transcript levels, respectively. Only AM1108 was able to be recognized by specific antibodies from infected bovines. This study allowed the identification of new candidate components of the outer-membrane fraction of A. marginale. Further studies will be required to analyze their potential as effective antigens for being included in rational vaccine strategies.

Indexed as

Anaplasma marginaleAnaplasmosisAnimalsAntibodies, BacterialAntigens, BacterialArgentinaBacterial Outer Membrane ProteinsCattleCattle DiseasesCell ProliferationConserved SequenceDNA, BacterialGene Expression ProfilingInterferon-gammaMolecular Sequence DataRecombinant ProteinsAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsDNA, BacterialInterferon-gammaRecombinant ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID24126603
OpenAlexW2006070431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.